SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)] [amend]
SEC Accession No. 0001144204-12-038527
Filing Date
2012-07-09
Accepted
2012-07-06 19:04:42
Documents
7
Period of Report
2011-09-30
Filing Date Changed
2012-07-06

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-Q v317702_10qa.htm 10-Q/A 16340
  Complete submission text file 0001144204-12-038527.txt   2000572

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT mslp-20110930.xml EX-101.INS 391556
3 XBRL TAXONOMY EXTENSION SCHEMA mslp-20110930.xsd EX-101.SCH 13195
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mslp-20110930_cal.xml EX-101.CAL 35183
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mslp-20110930_def.xml EX-101.DEF 80976
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mslp-20110930_lab.xml EX-101.LAB 115385
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mslp-20110930_pre.xml EX-101.PRE 95965
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-53166 | Film No.: 12951545
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1